pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CRO/CDMO · news · pharmadog
← back to CRO/CDMO
News · CRO/CDMO
155
stories
25d
Behind the scenes of 3 Big Pharma layoffs
biospace
27d
WuXi AppTec raises revenue forecast again in the face of DOD court case
endpoints
27d
BMS joins 3-year partnership to boost participation in cancer trials
fiercebiotech
27d
Boehringer, Microsoft team up to explore digital patient twins for clinical trials
fiercebiotech
27d
Australia's clinical trial advantage gains ground amid U.S. uncertainty
biospace
Oct 23, 26
Warp Sciences emerges from stealth, founded by ex-OpenAI science chief and tech veterans
endpoints
Oct 22, 26
Chutes & Ladders—Troubled CSL enlists GSK vet Deborah Waterhouse to lead
fiercebiotech
Oct 20, 26
Advocacy organization launches data dashboard to better assess how clinical trial sites perform
fiercebiotech
Oct 20, 26
AstraZeneca taps Oracle to help improve recruitment for clinical trials
fiercebiotech
Oct 19, 26
Pathos inks BMS, Tempus collabs to apply agentic AI in Alzheimer's clinical development
fiercebiotech
Oct 19, 26
How early should you engage a CDMO?
biopharma dive
Oct 19, 26
From strategy to scale: How Saudi Arabia is building a biotech ecosystem
biopharma dive
Oct 19, 26
More arms, more questions: The new challenge in multispecific drug design
biospace
Oct 16, 26
FDA considers interim access for compounded peptides; Enspryng's label expansion
endpoints
Oct 16, 26
STAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more
stat
Oct 15, 26
NorthStar's China CRO deal; Lonza details midterm guidance
endpoints
Oct 15, 26
The decisions behind scientific progress
biospace
Oct 14, 26
Agilent spends $240M upfront to buy digital pathology specialist Proscia
fiercebiotech
Oct 13, 26
IQVIA, Veeva expand on existing partnership for speedier clinical trials
fiercebiotech
Oct 13, 26
WCG unveils AI-powered solution to accelerate clinical trial kickoffs
fiercebiotech
Oct 12, 26
Successful CDMO partnerships hinge on honest—and sometimes critical—support
biospace
Oct 8, 26
Q3 layoffs down YOY, with 90% fewer biopharma employees affected
biospace
Oct 7, 26
ARPA-H unveils Surpass program to accelerate and expand clinical trials
fiercebiotech
Oct 6, 26
FDA extends review of Novo’s hemophilia A drug, citing manufacturing issues
biospace
Oct 6, 26
GE HealthCare to acquire Sofie Biosciences for $945M
biopharma dive
Oct 5, 26
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand
biospace
Oct 2, 26
How to Choose a Biologics CDMO: 4 Criteria That Matter the Most
fiercebiotech
Oct 1, 26
Foghorn lays off 40% of employees as Lilly cancer collab collapses over poor data
fiercebiotech
Sep 29, 26
Webinar: From Facility to Delivery: Solving the Complex Science of ADC Linker-Payload Synthesis
biospace
Sep 29, 26
SK pharmteco unveils $200M+ investment to expand CDMO capabilities
endpoints
← prev
page 2 of 6
next →